Robert Stagg, Pharm.D., Vice President, Clinical and Regulatory Affairs

Dr. Stagg is a Pharm.D. with extensive experience in Oncology drug development. Dr. Stagg joined Oncomed from PDL BioPharma where he served as Vice President of Regulatory and Drug Safety and prior to that as Senior Medical Director. Prior to PDL BioPharma, Dr. Stagg had served in a variety of clinical research capacities including Senior Director, Clinical Research for Tularik, Inc., Vice President, Clinical Research for Coulter Pharmaceutical, Director, Clinical Research at Gilead Sciences, Inc. and Medical Monitor at Genentech, Inc..

Dr. Stagg received his Pharm.D. from the University of the Pacific and he subsequently did his residency and Oncology fellowship at the University of California, San Francisco (UCSF). Subsequently, he joined the faculty at the UCSF where was an Assistant Clinical Professor from July 1983 to January 1991. While at UCSF his primary focus was Oncology clinical research.